Major trial tests promising new combo against advanced breast cancer
NCT ID NCT07085767
Summary
This large international study is testing whether a new drug called palazestrant works better than the current standard treatment when combined with another cancer drug called ribociclib. The trial will involve about 1,000 adults with advanced breast cancer that hasn't been treated with other medications yet. Researchers will compare how long patients live without their cancer getting worse between the two treatment groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGDenver, Colorado, 80220, United States
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGAmes, Iowa, 50010, United States
-
Clinical Trial Site
RECRUITINGScarborough, Maine, 04074, United States
-
Clinical Trial Site
RECRUITINGKansas City, Missouri, 64132, United States
-
Clinical Trial Site
RECRUITINGSanta Fe, New Mexico, 87505, United States
-
Clinical Trial Site
RECRUITINGColumbus, Ohio, 43219, United States
-
Clinical Trial Site
RECRUITINGSayre, Pennsylvania, 18840, United States
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGTennessee City, Tennessee, 37203, United States
-
Clinical Trial Site
NOT_YET_RECRUITINGSalt Lake City, Utah, 84106, United States
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGOlympia, Washington, 98502, United States
-
Clinical Trial Site
RECRUITINGSydney, New South Wales, 2109, Australia
-
Clinical Trial Site
RECRUITINGWaratah, New South Wales, 2298, Australia
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Clinical Trial Site
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Clinical Trial Site
RECRUITINGClayton, Victoria, 3168, Australia
-
Clinical Trial Site
RECRUITINGGeelong, Victoria, 3220, Australia
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Clinical Trial Site
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Clinical Trial Site
RECRUITINGToronto, Ontario, M2J 1V1, Canada
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGHong Kong, Hong Kong, 999077, Hong Kong
-
Clinical Trial Site
RECRUITINGHong Kong, Kowloon, 999077, Hong Kong
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGHong Kong, Pok Fu Lam, 999077, Hong Kong
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGKuching, Sarawak, 93586, Malaysia
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGApeldoorn, Gelderland, 7334 DZ, Netherlands
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGSeoul, Seoul, 02841, South Korea
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGSeoul, Seoul, 03080, South Korea
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGChang-hua, Chang Hua, 50006, Taiwan
-
Clinical Trial Site
RECRUITINGKaohsiung City, Sanmin, 80756, Taiwan
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGBangkok, Bangkok, 10700, Thailand
-
Clinical Trial Site
RECRUITINGDusit, Bangkok, 10300, Thailand
-
Clinical Trial Site
RECRUITINGBan Phaeo, Changwat Samut Sakhon, 74120, Thailand
-
Clinical Trial Site
RECRUITINGHat Yai, Changwat Songkhla, 90110, Thailand
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGChiang Mai, Chiang Mai, 50200, Thailand
-
Clinical Trial Site
RECRUITINGBrighton, England, BN2 5BE, United Kingdom
-
Clinical Trial Site
ACTIVE_NOT_RECRUITINGLondon, England, WC1E 6AG, United Kingdom
Conditions
Explore the condition pages connected to this study.